ZAFGEN SCHEDULE 13G - 2-12-15

Company

Larimar Therapeutics, Inc.

Filed

February 12, 2015

Accession Number

0001596770-15-000024

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →